Printer Friendly

Trace-forward investigation of mice in response to lymphocytic choriomeningitis virus outbreak.

Lymphocytic choriomeningitis virus (LCMV), a rodentborne arenavirus, causes inapparent infection in mice but can cause febrile illness, aseptic meningitis, encephalitis, and severe birth defects in humans ( ncidod/dvrd/spb/mnpages/dispages/lcmv.htm) (1). LCMV also can cause disseminated disease with substantial mortality among infected organ transplant recipients (2). The reservoir is the common house mouse, Mus musculus, but other rodents can become infected and transmit infection to humans. LCMV is endemic among house mice throughout the world, with antibody seroprevalence of 5%-13% in the United States (3). LCMV is easily maintained after being introduced into a captive mouse population because mice can persistently shed the virus. LCMV can be transmitted to humans through direct or aerosol contact with urine, feces, or saliva of infected rodents; through transplantation of infected organs; and from mother to fetus (1). Sporadic cases occur from exposure to peridomestic house mice, and outbreaks from exposure to infected rodents, particularly hamsters, kept as pets or used for laboratory experimentation have been reported (2,4-7). No outbreaks have been linked to contact with frozen mice.

During summer 2012, state and local agencies and the Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) investigated an outbreak of LCMV in the United States. A total of 31 (32%) of 97 tested employees of 3 rodent breeding facilities were infected because of the likely introduction of LCMV into the captive breeding population by wild mice. LCMV aseptic meningitis was diagnosed in 4 employees, and diagnostic testing of the breeding population identified LCMV infection among mice but not rats; no hamsters were bred at the facility (facility A in [8,9]). All mice originating from this captive breeding population were considered potentially infected and had been distributed to rodent purchasing facilities in multiple states by an Indiana rodent distributor, facility B. We describe the trace-forward investigation of live mice distributed by facility B and the public health measures taken to prevent additional human LCMV infections.

The Study

During July and August 2012, investigators from CDC's Viral Special Pathogens Branch reviewed shipping records from facility B and subsequent distributors and notified health departments in states that had received potentially infected mice during January 1--May 7, 2012; frozen mice were considered a low public health risk and were not traced. Health departments were provided with a list of facilities that had purchased these mice, educational resources about LCMV, and an algorithm to determine whether potentially infected mice remained at these purchasing facilities resulting from the presence, comingling, or breeding of these mice, which would maintain LCMV among the mouse population (Figure 1). As a result of varying state statutes concerning regulation and licensing of pet stores and animal breeders or distributors, the government agencies that had jurisdiction to perform these investigations included local and state departments of public health, environmental health, food safety, and agriculture.

State investigators interviewed purchasing facility managers by telephone, mail, email, or in person to determine whether potentially infected mice remained on the premises and to encourage euthanization of these mice. Interviews also assessed whether pregnant, ill, or immunocompromised employees might have been exposed to LCMV by directly handling potentially infected mice or bedding or equipment used for the mice. Because of risk for severe disease, facility managers were asked to offer serologic testing to these employees for LCMV IgM and IgG, which was performed by CDC by using ELISA as described (10). No additional case-finding activities were conducted. Because of resource limitations, diagnostic testing of live mice at purchasing facilities was not conducted.

Reviews of shipping records indicated that [approximately equal to] 304,000 live mice distributed by facility B were shipped to 561 purchasing facilities: 543 pet stores, 11 breeders or distributors, and 7 zoos or aquariums in 21 states, potentially exposing thousands of employees and pet store mouse purchasers to LCMV. Facility B had shipped mice to 4 subsequent distributors; the largest was located in Georgia, and it had shipped > 183,000 mice to 420 purchasing facilities in 16 states (Figure 2). Interviews of facility managers at purchasing facilities revealed that 48% still had potentially infected mice; > 10,000 mice were subsequently euthanized. The most common reason for still having potentially infected mice was comingling of rodent shipments, followed by breeding or still having mice from the original shipments.

Serologic testing was performed on blood samples from 34 pet store or zoo employees from 6 states who self-identified as pregnant or ill, were potentially exposed to LCMV, and agreed to serologic testing. Fourteen were pregnant; 1 had aseptic meningitis; and 23 reported nonspecific symptoms including fever, headache, body aches, cough, and vomiting. All persons tested were negative for antibodies against LCMV.


These captive feeder mice had a wide and complex distribution chain, potentially exposing thousands of persons to LCMV. No additional human cases were identified after distribution of these mice; none of the pet store or zoo employees tested had serologic evidence of infection. Although no additional human cases were identified, euthanasia of all potentially infected rodents was recommended to mitigate potential risk.

Wild mice that access captive breeding populations are often the source of infection of captive rodent populations (8,11). After being introduced, LCMV transmission is easily maintained among mouse colonies and is difficult to recognize because mice do not appear ill. Because persistently infected mice pass infection to their offspring, the number of infected mice in a breeding colony can quickly multiply. Mice can be persistently infected without having serologic evidence of infection (12); thus, LCMV can be missed by serologic screening alone. Therefore, preventing introduction of the virus into breeding colonies, depopulation of infected rodents, and correct use of personal protective equipment are the most efficient ways to mitigate human exposure. We recommend preventive measures at each point in the distribution process, both domestically and abroad (Table) (13-15). More research is needed to develop methods for detecting LCMV in rodents at distributors and pet stores.

Our investigation had several limitations. Employees tested were a fraction of those who had had contact with potentially infected mice. Also, pet store mouse purchasers and purchasing facility employees were difficult to contact, and no pet store customers were tested. Thus, the true number of infected persons is unknown.

Rodent breeders and distributors can fall through a regulatory gap in the United States. Frozen feeder mice are considered pet food and can be regulated by the Food and Drug Administration (FDA), but neither FDA nor the US Department of Agriculture has the authority to regulate live mice and rats because they are not regulated under the Animal Welfare Act (7 CFR 2132, May 13, 2002, www.aphis. and the Food, Drug and Cosmetics Act (21 CFR 500, April 1, 2012, CFRSearch.cfm?CFRPart=500&showFR=1). Therefore, regulatory authority falls to the states, which have an array of regulations governing the handling, breeding, and distribution of rodents, including the licensing of pet breeders surfaces of the protective gear, and workers should wash their hands after removing gloves. and distributors (15; Thomas Edling, pers. comm.), as was evident in this trace-forward investigation. Because of the lack of consistent regulation, we recommend that state and federal partners and rodent industry advisory groups work with breeders, distributors, and pet stores to increase awareness of LCMV infection and implement recommended best practices (Table) to prevent introduction of LCMV into captive rodent populations, prevent subsequent dissemination of potentially infected rodents, and reduce the potential for human exposure and disease among employees and consumers of pet stores and rodent breeding facilities.

Additional members of the Multistate LCMV Outbreak Working Group who contributed data: Jennifer House (Indiana State Department of Health); Gary Balsamo (Louisiana Department of Health and Hospitals); Erin Delaune (Louisiana Office of Public Health); Susan Weinstein (Arkansas Department of Health); Bryan Buss, Manjiri Joshi, and Andre Braith (Nebraska Department of Health and Human Services); Katherine Feldman (Maryland Department of Health and Mental Hygiene); Elizabeth Santini (Pennsylvania Department of Agriculture); Virginia Dato and James Rankin (Pennsylvania Department of Health); Stephanie Cox and Kate Habicht (South Carolina Department of Health and Environmental Control); Ellen Salehi, Mary DiOrio, Kim Quinn, and Kathleen Smith (Ohio Department of Health); Sara Robeson, Kathy Fowler, and John Poe (Kentucky Department for Public Health); Clay Horton and Jessica Austin (Green River District Health Department, Kentucky); and Heather Henderson and Rand Carpenter (Tennessee Department of Health).


This investigation was a collaborative effort, and we acknowledge Thomas Edling and Edward Weiss for their contributions.

Dr Edison is an Epidemic Intelligence Service officer assigned to the Georgia Department of Public Health, Acute Disease Epidemiology Section, CDC, Atlanta, Georgia. Her research interests include zoonotic diseases, health care--associated infections, and outbreak investigations.


(1.) Oldstone MB. Biology and pathogenesis of lymphocytic choriomeningitis virus infection. Curr Top Microbiol Immunol. 2002; 263:83-117.

(2.) MacneilA, Stroher U, Farnon E, Campbell S, Cannon D, Paddock CD, et al. Solid organ transplant-associated lymphocytic choriomeningitis, United States, 2011. Emerg Infect Dis. 2012; 18:1256-62.

(3.) Childs JE, Glass GE, Korch GW, Ksiazek TG, Leduc JW. Lymphocytic choriomeningitis virus infection and house mouse (Mus musculus) distribution in urban Baltimore. Am J Trop Med Hyg. 1992; 47:27-34.

(4.) Dykewicz CA, Dato VM, Fisher-Hoch SP, Howarth MV, PerezOronoz GI, Ostroff SM, et al. Lymphocytic choriomeningitis outbreak associated with nude mice in a research institute. JAMA. 1992; 267:1349-53. jama.1992.03480100055030

(5.) Smith AL, Paturzo FX, Gardner EP, Morgenstern S, Cameron G, Wadley H. Two epizootics of lymphocytic choriomeningitis virus occurring in laboratory mice despite intensive monitoring programs. Can J Comp Med. 1984; 48:335-7.

(6.) Biggar RJ, Woodall JP, Walter PD, Haughie GE. Lymphocytic choriomeningitis outbreak associated with pet hamsters. Fifty-seven cases from New York State. JAMA. 1975; 232:494-500.

(7.) Gregg MB. Recent outbreaks of lymphocytic choriomeningitis in the United States of America. Bull World Health Organ. 1975; 52:549-53.

(8.) Knust B, Stroher U, Edison L, Albarino CG, Lovejoy J, Armeanu E, et al. Lymphocytic choriomeningitis virus in employees and mice at multipremises feeder-rodent operation, USA, 2012. Emerg Infect Dis. 2014; 20:240-7.

(9.) Centers for Disease Control and Prevention. Notes from the field: lymphocytic choriomeningitis virus infections in employees of a rodent breeding facility--Indiana, May-June 2012. MMWR Morb Mortal Wkly Rep. 2012; 61:622-3.

(10.) Park JY, Peters CJ, Rollin PE, Ksiazek TG, Katholi CR, Waites KB, et al. Age distribution of lymphocytic choriomeningitis virus serum antibody in Birmingham, Alabama: evidence of a decreased risk of infection. Am J Trop Med Hyg. 1997; 57:37-41.

(11.) Salvato MS, editor. The Arenaviridae. New York: Plenum Press; 1993.

(12.) Hanaoka M, Suzuki S, Hotchin J. Thymus-dependent lymphocytes: destruction by lymphocytic choriomeningitis virus. Science. 1969; 163:1216-9. 3872.1216

(13.) Shek WR. Lymphocytic choriomeningitis virus. In: Waggie K, Kagiyama N, Allen AM, Nomura T, editors. Manual of microbiologic monitoring of laboratory animals. 2nd ed. Bethesda (MD): US Department of Health and Human Services; 1994. p. 35-42.

(14.) Centers for Disease Control and Prevention. Interim guidance for minimizing risk for human lymphocytic choriomeningitis virus infection associated with rodents. MMWR Morb Mortal Wkly Rep. 2005; 54:747-9.

(15.) Hardin S. Best management practices for feeder rodent production and distribution. [2013 Nov 1]. files/pdfs/FeederRodentIndustryBMPSept2013.pdf

Laura Edison, Barbara Knust, Bret Petersen, Julie Gabel, Craig Manning, Cherie Drenzek, Ute Stroher, Pierre E. Rollin, Douglas Thoroughman, Stuart T. Nichol, and the Multistate LCMV Outbreak Working Group [1]

[1] Additional members of the Multistate LCMV Outbreak Working Group who contributed data are listed at the end of this article.

Address for correspondence: Laura Edison, Georgia Department of Public Health, Acute Disease Epidemiology Section, 2 Peachtree St NW Suite 14-232, Atlanta, GA 30303, USA; email:

Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (L. Edison, B. Knust, B. Petersen, C. Manning, U. Stroher, P.E. Rollin, D. Thoroughman, S.T. Nichol); Georgia Department of Public Health, Atlanta (L. Edison, J. Gabel, C. Drenzek); and Kentucky Department for Public Health, Lexington, Kentucky, USA (D. Thoroughman)


Table. Recommendations for the prevention and control of
lymphocytic choriomeningitis virus among rodents and persons who
handle them

Preventing lymphocytic choriomeningitis virus (LCMV) from being
introduced into a rodent breeding colony

* All rodents introduced into the breeding colony facility should
come from a facility with a biosecurity and monitoring program for
LCMV in place.

* Contact between wild mice and breeding colony animals should be
prevented through exclusion and by trapping of escaped and feral
mice; rodent traps should be placed at the perimeter of the
facility, in rodent rooms, and in areas where feed is stored.

* Any feral rodents or colony rodents that escape should be removed
and euthanized.

* Testing for LCMV should be included in the routine health
monitoring for the colony._

Preventing the spread of LCMV within a rodent breeding colony

* Movement of animals between rooms should be restricted;
replacement breeding animals remain within the room they were born,
and animals only leave rooms to be removed from the facility.

* Equipment used in handling used cages or bedding should not be
shared between rooms or used to handle clean cages or bedding, and
such equipment should be disinfected regularly.

* Employees should wear waterproof washable or disposable footwear
that can be cleaned between rooms, and they should wear designated
coveralls or laboratory coats for each building or room. Footwear
should be disinfected before exit and entry into each room.

* After LCMV is discovered, all rodents in the affected rooms or
colony should be euthanized.

Preventing infection or the spread of infection at the rodent
distributor or pet store

* Rodents should be purchased only from suppliers with biosecurity
and monitoring programs.

* Comingling of rodents from different shipments and between rodent
species should be prevented.

* Contact between wild mice and captive rodents should be prevented
through exclusion and by trapping of escaped rodents and wild mice;
rodent traps should be placed at the perimeter of the facility, in
rodent rooms, and in areas where feed is stored.

* Equipment used in handling used cages or bedding should not be
shared between shipments of rodents or used to handle clean cages
or bedding, and such equipment should be disinfected regularly._

Preventing infection among persons who handle rodents

* Employees who handle rodents should be educated about the risk
for LCMV, and educational material should be distributed at the
point of purchase in pet stores.

* Gloves should be used during handling of live or frozen rodents,
used bedding, and dirty cages; hands should be promptly washed when
gloves are removed.

* Pregnant and immunocompromised persons should be advised not to
directly handle rodents or clean cages.

* Employees should not eat, drink, or smoke in rodent rooms.

Handling rodents with known LCMV infection

* A respirator with a filter of >N95 rating, filtering face piece,
elastomeric half or full mask, or powered air-purifying respirator
should be worn; respiratory capacity testing and fit testing are
necessary for all persons wearing such gear.

* Gloves, waterproof and washable footwear, and coveralls should be
worn; disinfectant should be used to clean the external
COPYRIGHT 2014 U.S. National Center for Infectious Diseases
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:DISPATCHES
Author:Edison, Laura; Knust, Barbara; Petersen, Bret; Gabel, Julie; Manning, Craig; Drenzek, Cherie; Strohe
Publication:Emerging Infectious Diseases
Article Type:Author abstract
Date:Feb 1, 2014
Previous Article:Crimean-Congo hemorrhagic fever virus, Greece.
Next Article:Rift Valley fever outbreak, Southern Mauritania, 2012.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters